Abstract
Summary: Acute intermittent porphyria (AIP) is an inherited disorder in the haem biosynthetic pathway caused by a partial deficiency of porphobilinogen (PBG) deaminase. To date, more than 200 different mutations have been identified in the PBG deaminase gene (PBGD) in AIP patients from various countries and ethnic groups. While the majority of the PBGD gene mutations, including most of the mutations occurring at CpG dinucleotides, are family-specific, a few CpG mutations have been observed in a number of AIP patients of European origin. To study the origin of these common CpG mutations, eight intragenic single-nucleotide polymorphisms (SNPs) in the PBGD gene, as well as eight microsatellites flanking the gene in chromosome 11 were used to construct haplotypes in six AIP families of German, Polish and Swiss origins who carried either G111R (4707G>;A) or R173Q (6391G>;A) mutations. Among the three R173Q families, three distinct haplotypes were found to be cosegregated with the mutation. One Swiss and one German G111R family shared partially an intragenic and its extended microsatellite haplotype, whereas the Polish G111R family showed a unique haplotype. These results indicated that the recurrent CpG mutations that exist in the European AIP population can be either of ancestral origins or derived from de novo events.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Anderson K, Sassa S, Bishop D, Desnick R (2001) The porphyrias.In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds; Childs B, Kinzler KW, Vogelstein B, assoc.eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn.New York: McGraw-Hill, 2991–3062.
Broman K, Murray J, Sheffield V, White R, Weber J (1998) Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 63: 861–869.
Collins A, Frezal J, Teague J, Morton NE (1996) A metric map of humans: 23,500 loci in 850 bands. Proc Natl Acad Sci USA 93: 14771–14775.
Delfau M, Picat C, de Rooij F, et al (1990) Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria. J Clin Invest 86: 1511–1516.
De Siervi A, Rossetti M, Parera V, et al (1999) Identifiation and characterization of hydroxymethylbilane synthase mutations causing acute intermittent porphyria: evidence for an ancestral founder of the common G111R mutation. Am J Med Genet 86: 366–375.
Gregor A, Schneider-Yin X, Szlendak U, et al (2002) Molecular study of the porphobilinogen deaminase gene among Polish patients with acute intermittent porphyria. Hum Mutat 19: 310.
Gu X, de Rooij F, de Baar E, et al (1993) Two novel mutations of the porphobilinogen deaminase gene in acute intermittent porphyria. Hum Mol Genet 2: 1735–1736.
Kauppinen R, Mustajoki S, Pihlaja H, Peltonen L, Mustajoki P (1995) Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene. HumMol Genet 4: 215–222.
Puy H, Deybach JC, Lamoril J, et al (1997) Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. Am J Hum Genet 60: 1373–1383.
Ramdall R, Cunha L, Astrin K, et al (2000) Acute intermittent porphyria: novel missense mutations in the human hydroxymethylbilane synthase gene. Genet Med 2: 290–295.
Robreau-Fraolini A, Puy H, Aquaron C, et al (2000) Porphobilinogen deaminase gene in African and Afro-Caribbean ethnic groups: mutations causing acute intermittent porphyria and specific intragenic polymorphisms. Hum Genet 107: 150–159.
Rosipal R, Puy H, Lamoril J, Martasek P, Nordmann Y, Deybach JC (1997) Molecular analysis of porphobilinogen (PBG) deaminase gene mutations in acute intermittent porphyria: first study in patients of Slavic origin. Scand J Clin Invest 57: 217–224.
Schneider-Yin X, Bogard C, Rüfenacht U, et al (2000) Identifiation of a prevalent nonsense mutation (W283X) and two novel mutations in the porphobilinogen deaminase gene of Swiss patients with acute intermittent porphyria. Hum Hered 50: 247–250.
Schneider-Yin, Hergersberg M, Rüfenacht U, et al (2002) Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among Swiss and French patients with acute intermittent porphyria. Hum Hered 54: 69–81.
Schuurmans MM, Schneider-Yin X, Rüfenacht U, et al (2001) Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients. Mol Med 7: 535–542.
Solis C, Lopez-Echaniz I, Sefarty-Graneda D, Astrin K, Desnick R (1999) Identifiation and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria. Mol Med 5: 664–671.
Waters T, Swann P (2000) Thymine-DNA glycosylase and G to A transition mutations at CpG sites. Mutat Res 462: 137–147.
Whately S, Woolf J, Elder G (1999) Comparison of complementary and genomic DNA sequencing for the detection of mutations in the HMBS gene in British patients with acute intermittent porphyria: identification of 25 novel mutations. Hum Genet 104: 505–510.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schneider-Yin, X., Hergersberg, M., Schuurmans, M.M. et al. Mutation hotspots in the human porphobilinogen deaminase gene: Recurrent mutations G111R and R173Q occurring at CpG motifs. J Inherit Metab Dis 27, 625–631 (2004). https://doi.org/10.1023/B:BOLI.0000042936.20691.ad
Issue Date:
DOI: https://doi.org/10.1023/B:BOLI.0000042936.20691.ad